FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020189206> ?p ?o ?g. }

• W2020189206 endingPage "e18200" @default.
• W2020189206 startingPage "e18200" @default.
• W2020189206 abstract "Targeting pro-inflammatory events to reduce seizures is gaining momentum. Experimentally, antagonism of inflammatory processes and of blood-brain barrier (BBB) damage has been demonstrated to be beneficial in reducing status epilepticus (SE). Clinically, a role of inflammation in the pathophysiology of drug resistant epilepsies is suspected. However, the use anti-inflammatory drug such as glucocorticosteroids (GCs) is limited to selected pediatric epileptic syndromes and spasms. Lack of animal data may be one of the reasons for the limited use of GCs in epilepsy. We evaluated the effect of the CG dexamethasone in reducing the onset and the severity of pilocarpine SE in rats. We assessed BBB integrity by measuring serum S100β and Evans Blue brain extravasation. Electrophysiological monitoring and hematologic measurements (WBCs and IL-1β) were performed. We reviewed the effect of add on dexamethasone treatment on a population of pediatric patients affected by drug resistant epilepsy. We excluded subjects affected by West, Landau-Kleffner or Lennox-Gastaut syndromes and Rasmussen encephalitis, known to respond to GCs or adrenocorticotropic hormone (ACTH). The effect of two additional GCs, methylprednisolone and hydrocortisone, was also reviewed in this population. When dexamethasone treatment preceded exposure to the convulsive agent pilocarpine, the number of rats developing status epilepticus (SE) was reduced. When SE developed, the time-to-onset was significantly delayed compared to pilocarpine alone and mortality associated with pilocarpine-SE was abolished. Dexamethasone significantly protected the BBB from damage. The clinical study included pediatric drug resistant epileptic subjects receiving add on GC treatments. Decreased seizure frequency (≥50%) or interruption of status epilepticus was observed in the majority of the subjects, regardless of the underlying pathology. Our experimental results point to a seizure-reducing effect of dexamethasone. The mechanism encompasses improvement of BBB integrity. Our results also suggest that add on GCs could be of efficacy in controlling pediatric drug resistant seizures." @default.
• W2020189206 created "2016-06-24" @default.
• W2020189206 creator A5008413693 @default.
• W2020189206 creator A5013776228 @default.
• W2020189206 creator A5028259661 @default.
• W2020189206 creator A5036848377 @default.
• W2020189206 creator A5043785363 @default.
• W2020189206 creator A5049237819 @default.
• W2020189206 creator A5062771449 @default.
• W2020189206 creator A5072148725 @default.
• W2020189206 creator A5075141154 @default.
• W2020189206 date "2011-03-28" @default.
• W2020189206 modified "2023-10-18" @default.
• W2020189206 title "Efficacy of Anti-Inflammatory Therapy in a Model of Acute Seizures and in a Population of Pediatric Drug Resistant Epileptics" @default.
• W2020189206 cites W1504424992 @default.
• W2020189206 cites W1964785025 @default.
• W2020189206 cites W1966697781 @default.
• W2020189206 cites W1969264405 @default.
• W2020189206 cites W1970241565 @default.
• W2020189206 cites W1971775352 @default.
• W2020189206 cites W1976582395 @default.
• W2020189206 cites W1977291679 @default.
• W2020189206 cites W1988657178 @default.
• W2020189206 cites W1999228646 @default.
• W2020189206 cites W2003563674 @default.
• W2020189206 cites W2006780533 @default.
• W2020189206 cites W2011075382 @default.
• W2020189206 cites W2016385700 @default.
• W2020189206 cites W2017081573 @default.
• W2020189206 cites W2018609239 @default.
• W2020189206 cites W2022796522 @default.
• W2020189206 cites W2030098805 @default.
• W2020189206 cites W2031120775 @default.
• W2020189206 cites W2037793593 @default.
• W2020189206 cites W2038400236 @default.
• W2020189206 cites W2043132687 @default.
• W2020189206 cites W2049278300 @default.
• W2020189206 cites W2053222899 @default.
• W2020189206 cites W2056326370 @default.
• W2020189206 cites W2056643778 @default.
• W2020189206 cites W2060969086 @default.
• W2020189206 cites W2070712385 @default.
• W2020189206 cites W2072649503 @default.
• W2020189206 cites W2078412655 @default.
• W2020189206 cites W2080457800 @default.
• W2020189206 cites W2081689918 @default.
• W2020189206 cites W2082634781 @default.
• W2020189206 cites W2085773106 @default.
• W2020189206 cites W2087982685 @default.
• W2020189206 cites W2094778668 @default.
• W2020189206 cites W2096133482 @default.
• W2020189206 cites W2106013244 @default.
• W2020189206 cites W2108170307 @default.
• W2020189206 cites W2112937635 @default.
• W2020189206 cites W2122159273 @default.
• W2020189206 cites W2127587930 @default.
• W2020189206 cites W2133718268 @default.
• W2020189206 cites W2166904841 @default.
• W2020189206 cites W2171255613 @default.
• W2020189206 doi "https://doi.org/10.1371/journal.pone.0018200" @default.
• W2020189206 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3065475" @default.
• W2020189206 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21464890" @default.
• W2020189206 hasPublicationYear "2011" @default.
• W2020189206 type Work @default.
• W2020189206 sameAs 2020189206 @default.
• W2020189206 citedByCount "127" @default.
• W2020189206 countsByYear W20201892062012 @default.
• W2020189206 countsByYear W20201892062013 @default.
• W2020189206 countsByYear W20201892062014 @default.
• W2020189206 countsByYear W20201892062015 @default.
• W2020189206 countsByYear W20201892062016 @default.
• W2020189206 countsByYear W20201892062017 @default.
• W2020189206 countsByYear W20201892062018 @default.
• W2020189206 countsByYear W20201892062019 @default.
• W2020189206 countsByYear W20201892062020 @default.
• W2020189206 countsByYear W20201892062021 @default.
• W2020189206 countsByYear W20201892062022 @default.
• W2020189206 countsByYear W20201892062023 @default.
• W2020189206 crossrefType "journal-article" @default.
• W2020189206 hasAuthorship W2020189206A5008413693 @default.
• W2020189206 hasAuthorship W2020189206A5013776228 @default.
• W2020189206 hasAuthorship W2020189206A5028259661 @default.
• W2020189206 hasAuthorship W2020189206A5036848377 @default.
• W2020189206 hasAuthorship W2020189206A5043785363 @default.
• W2020189206 hasAuthorship W2020189206A5049237819 @default.
• W2020189206 hasAuthorship W2020189206A5062771449 @default.
• W2020189206 hasAuthorship W2020189206A5072148725 @default.
• W2020189206 hasAuthorship W2020189206A5075141154 @default.
• W2020189206 hasBestOaLocation W20201892061 @default.
• W2020189206 hasConcept C118552586 @default.
• W2020189206 hasConcept C126322002 @default.
• W2020189206 hasConcept C2777204577 @default.
• W2020189206 hasConcept C2777341932 @default.
• W2020189206 hasConcept C2778186239 @default.
• W2020189206 hasConcept C2778337148 @default.
• W2020189206 hasConcept C2780401358 @default.
• W2020189206 hasConcept C2908647359 @default.
• W2020189206 hasConcept C42219234 @default.

• next